Skip to content

Clinical Research of Midazolam Combining with Sufentanil in Patients Undergoing Transesophageal Echocardiography

Clinical Research of Midazolam Combining with Sufentanil in Patients Undergoing Transesophageal Echocardiography

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17010725
Enrollment
Unknown
Registered
2017-02-24
Start date
2017-02-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular disease

Interventions

Contol group:Pharyngeal topical anesthesia
M group:Pharyngeal topical anesthesia pius midazolam i.v.
MS group:Pharyngeal topical anesthesia plus midazolam, sufentanyl i.v.

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged >18 years; Inpatients with ASA I-III class underwent transesophageal echocardiography

Exclusion criteria

Exclusion criteria: Complex congenital heart disease, severe heart failure without control (heart function IV level), severe ventricular arrhythmias, sleep apnea, the narcotic drug allergy, taking psychotropic drugs and other anesthesia taboo (upper respiratory tract infection), transesophageal ultrasound examination contraindications (such as esophageal diverticulum)

Design outcomes

Primary

MeasureTime frame
operation time;Patient satisfaction;Ease of probe insertion;Ease and quality of the procedure;Time-to-discharge;

Countries

China

Contacts

Public Contactlyzerd

The Second Hospital of Hebei Medical University,

47243302@qq.com+86 13111531186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026